This is the authors' abstract. We don't add key points for this paper.
Sir, Our report1 on the long‐term effect of terbinafine treatment on mycotic toenail infections has been criticized from a statistical and evaluation point of view. In responding, it is important to state that this study was performed without support of any kind from any pharmaceutical company. The patients involved in this study were individuals who had suffered from their mycotic toenail infections for many years, reporting considerable impairment of their quality of life by thickening of the nails which made the use of proper shoes difficult, due to pain and/or odour. They were treated during the period immediately after the registration of terbinafine in Sweden. The criteria for initiating treatment were a widespread infection and different complaints, not only cosmetic, due to the nail infection. Thus, in some ways, they were a selected patient population. We, of course, agree that there is always a need for criteria in evaluating the results of various treatments in all fields of medicine. However, from the patient’s point of view, the importance is not only to have good‐looking nails but to be free from all discomfort irrespective of residual discolourations. How many toenails are really completely free of any dystrophic or colour disfiguration in adults? We therefore used the term ‘response’ and not ‘without any sign of disease’. Of course the ideal patients are those who have been recorded as having toenails ‘without any sign of disease’ already before being infected, but where do you find them?
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Molin et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: